Swiss pharma giant Roche to invest $50bn in US within five years
Roche plans to invest 50 billion dollars in the USA within 5 years
Keystone-SDA
Select your language
Generated with artificial intelligence.
Listening: Swiss pharma giant Roche to invest $50bn in US within five years
Swiss pharmaceutical company Roche plans to invest up to $50 billion (CHF40.5 billion) in the United States over the next five years. Fellow Basel-based pharma company Novartis had already announced investments totalling billions almost a fortnight ago.
This content was published on
3 minutes
Keystone-SDA
Deutsch
de
Roche will innert 5 Jahren 50 Milliarden Dollar in USA investieren
Original
According to a press release issued by Roche on Tuesday, the money is to be invested in both existing sites and new production facilities. The expansion would create up to 12,000 new jobs – around 1,000 at the pharmaceutical company alone and a further 11,000 to support the new US production capacities.
The funds will be channelled into US production and sales capacities for both the pharmaceuticals and diagnostics divisions. A state-of-the-art production facility for gene therapy is planned in Pennsylvania.
Roche is also planning a new 900,000 square metre manufacturing centre to support its growing portfolio of next-generation weight loss medicines. The location of this centre is yet to be announced.
In addition, Roche will invest in a new research and development centre in Massachusetts to conduct cutting-edge research in artificial intelligence and serve as a hub for new research and development activities in cardiovascular, renal and metabolic areas.
More
More
Roche’s big bet on big diseases
This content was published on
Swiss pharma giant Roche is the latest company to refocus its R&D investment on diseases like obesity that weigh heavily on healthcare budgets.
“The investments announced today emphasise our long-standing commitment to research, development and production in the US,” CEO Thomas Schinecker is quoted as saying in the press release. The Group has been engaged in the US for 110 years as an important driver of jobs, innovation and the creation of intellectual property in both the pharmaceutical and biotechnology industries in the US.
Once all new and expanded production capacities are operational, Roche will export more medicines from the US than it imports.
Adapted from German by DeepL/jdp
How we work
We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. An editor then briefly reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
Did you find this explanation helpful? Please fill out this short survey to help us understand your needs by clicking hereExternal link.
Popular Stories
More
Aging society
No house generation: the impossibility of buying property in Switzerland
Survey: most Swiss ready to steer clear of US products due to tariffs
This content was published on
A majority of Swiss and European consumers say they are prepared to opt out of buying American products like Coca-Cola and Nike in protest at US tariffs, a study shows.
This content was published on
The World Health Organization (WHO) boss, Tedros Adhanom Ghebreyesus, says the Geneva-based UN agency has revised down its budget to $4.2 billion (CHF3.5 billion) for 2026-2027.
Swiss police break up major Chinese trafficking ring
This content was published on
Bern cantonal police have smashed a major human trafficking ring. Five people are accused of luring over 100 Chinese women to Switzerland to exploit them as sex workers.
‘Imminent’ landslide threat: authorities order full evacuation of Swiss mountain village
This content was published on
The local authorities have ordered the complete evacuation of the village of Blatten and its 300 residents due to "imminent" dangers.
Swiss health survey: 52% of men are overweight, 34% of women
This content was published on
The results of the Swiss Health Survey 2022 reveal clear differences between men and women: 55% of women and 44% of men live with at least one chronic illness.
This content was published on
Switzerland plans to give an additional $80 million (CHF67 million) for the 2025-2028 period to the World Health Organization (WHO), which is facing financial difficulties.
Over half a million people attended Eurovision shows or events in Basel
This content was published on
Over 500,000 people attended Eurovision Song Contest (ESC) shows or related events in Basel last week, the organisers said on Monday, celebrating its "great success".
Appenzell village is named ‘lightning capital’ of Switzerland
This content was published on
Gonten in canton Appenzell Inner Rhodes recorded the highest number of lightning strikes per square kilometre in Switzerland last year.
Swiss centre records almost 300 victims of human trafficking
This content was published on
Last year, 208 victims contacted the specialist unit FIZ Advocacy and Support for Migrant Women and Victims of Trafficking. For 59 others, an examination is still underway.
Swiss mountain village threatened by serious landslide risk
This content was published on
The situation in the mountain village of Blatten, canton Valais, remains serious due to the threat of a landslide, Swiss officials said on Sunday afternoon.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.